Patient-ventilator asynchrony during assisted mechanical ventilation

2008 ◽  
Vol 2008 ◽  
pp. 33-34
Author(s):  
I. Cinel
1987 ◽  
Vol 2 (2) ◽  
pp. 101-108 ◽  
Author(s):  
J.J. Fargier ◽  
D. Robert ◽  
F. Boyer ◽  
J. Chagny ◽  
C. Kopp ◽  
...  

2018 ◽  
Vol 2018 ◽  
pp. 1-5 ◽  
Author(s):  
Hugo Martínez-Rojano ◽  
Julio C. Noguez ◽  
Herón Huerta

The presence of nosocomial myiasis reflects a lack of adequate medical attention, due to the physical facilities and/or the health care personnel. Patients requiring special attention are more susceptible, such as those with a loss of consciousness, assisted mechanical ventilation, tracheal tubes, or nasogastric probes. Nosocomial myiasis is a rare event that has a greater occurrence in the hospitals of poor and developing countries. The two cases herein described represent the first report of nosocomial myiasis in Mexico. The causal agents were found to be Lucilia sericata and Sarcophaga spp. The taxonomical identification of the larvae of the second and third instar was based on the morphology of the cephaloskeleton, anterior spiracles, and peritreme plaques.


CHEST Journal ◽  
1990 ◽  
Vol 98 (2) ◽  
pp. 458-462 ◽  
Author(s):  
Edward K. McGough ◽  
Michael J. Banner ◽  
Philip G. Boysen

2022 ◽  
Vol 12 (1) ◽  
Author(s):  
Rodolfo Guardado-Mendoza ◽  
Miguel Angel Garcia-Magaña ◽  
Liz Jovanna Martínez-Navarro ◽  
Hilda Elizabeth Macías-Cervantes ◽  
Rodolfo Aguilar-Guerrero ◽  
...  

AbstractTo evaluate the effect of the combination of linagliptin and insulin on metabolic control and prognosis in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and hyperglycemia. A parallel double-blind randomized clinical trial including hospitalized patients with SARS-CoV-2 infection and hyperglycemia, randomized to receive 5 mg linagliptin + insulin (LI group) or insulin alone (I group) was performed. The main outcomes were the need for assisted mechanical ventilation and glucose levels during hospitalization. Subjects were screened for eligibility at hospital admission if they were not with assisted mechanical ventilation and presented hyperglycemia, and a total of 73 patients with SARS-CoV-2 infection and hyperglycemia were randomized to the LI group (n = 35) or I group (n = 38). The average hospital stay was 12 ± 1 vs 10 ± 1 days for the I and LI groups, respectively (p = 0.343). There were no baseline clinical differences between the study groups, but the percentage of males was higher in the LI group (26 vs 18, p = 0.030). The improvements in fasting and postprandial glucose levels were better in the LI group that the I group (122 ± 7 vs 149 ± 10, p = 0.033; and 137 ± 7 vs 173 ± 12, p = 0.017, respectively), and insulin requirements tended to be lower in the LI group than the I group. Three patients in the LI group and 12 in the I group required assisted mechanical ventilation (HR 0.258, CI 95% 0.092–0.719, p = 0.009); 2 patients in the LI group and 6 in the I group died after a follow-up of 30 days (p = 0.139). No major side effects were observed. The combination of linagliptin and insulin in hospitalized patients with SARS-CoV-2 infection and hyperglycemia reduced the relative risk of assisted mechanical ventilation by 74% and improved better pre and postprandial glucose levels with lower insulin requirements, and no higher risk of hypoglycemia.This study is registered at clinicaltrials.gov, number NCT04542213 on 09/03/2020.


CHEST Journal ◽  
1985 ◽  
Vol 88 (5) ◽  
pp. 799-800
Author(s):  
Philip A Tomasello ◽  
Judith A. Culpepper ◽  
Michael J. Buran

2018 ◽  
pp. 144-144
Author(s):  
Atul Kulkarni ◽  
Suhail Siddiqui ◽  
Vikas Bhagat

Sign in / Sign up

Export Citation Format

Share Document